Read + Share
Amedeo Smart
Independent Medical Education
Barcellini W, Pane F, Patriarca A, Murakhovskaya I, et al. Parsaclisib for the treatment of primary autoimmune hemolytic anemia: Results from a phase 2, open-label study. Am J Hematol 2024 Oct 22. doi: 10.1002/ajh.27493.PMID: 39435908
Email
LinkedIn
Privacy Policy